The age of pharmaceutical microchipping is now upon us. Novartis AG, one of the largest drug companies in the world, has announced a plan to begin embedding microchips in medications to create "smart pill" technology..... Novartis apparently isn't planning on conducting any clinical trials that might take into account the safety issues of swallowing microchips. "Novartis does not expect to have to conduct full-scale clinical trials to prove the new products work," reports Reuters. "Instead, it aims to do so-called bioequivalence tests to show they are the same as the original."
More Here
No comments:
Post a Comment